Nick Wronski

5 posts

Posts (5)

Nick Wronski RXDX 3 years ago #1

Cramer is talking about it, they are toast ??

Nick Wronski RXDX 3 years ago #4

Great company with great research, these prices are completely reasonable with a full approved drug, but right now it’s respectfully a 65-75 dollar stock.

Nick Wronski RXDX 3 years ago #5

Great run coming to an end, market isn’t feasible to hold these prices